Speakers | Clinical Neuroscience Consortium Annual Forum

支持臨床神經科學聯盟

Professor Jacques HUGON

MD PhD Neurologist

University of Paris Cité

After studying medicine at the Faculty of Medicine in Paris, Professor Hugon completed an internship in neurology at the University of Limoges. He then worked as a physician at Taez Hospital in Yemen and served as a Research Associate at the Albert Einstein College of Medicine in New York from 1984 to 1986. During this period, he obtained a PhD in neuroscience from the University of Paris, focusing on Guam’s disease, which combines features of Parkinson’s disease, dementia, and amyotrophic lateral sclerosis.

After serving for two years as a hospital practitioner in neurology, he was appointed full professor at the Faculty of Medicine in Limoges in 1989, while also working as a consultant neurologist. In the late 1990s, he was appointed Chair of Anatomy at the Faculty of Medicine of The University of Hong Kong and Queen Mary Hospital, where he became Head of Department.

Upon his return to France in 2003, he was appointed full professor at Poitiers University Hospital, working in the Department of Neurology. Since 2006, he has been a full professor at the Faculty of Medicine of Université Paris Cité and at Lariboisière Hospital, where he led the Center for Cognitive Neurology for 12 years.

He has been an Honorary Professor at The University of Hong Kong and is Emeritus Professor at Université Paris Cité. He is a consultant neurologist at Lariboisière Hospital in Paris (Center for Cognitive Neurology) and at the Center for Advanced Neurology in Paris. His is a member of the Inserm Unit 1144, of the World Federation of Neurology and the European Federation of Neurology as well as the European Alzheimer’s Disease Consortium. His current clinical and research interests include biomarkers and molecular signaling changes in neurons in Alzheimer’s disease and other neurodegenerative disorders, as well as long COVID. He has authored more than 400 publications.

支持臨床神經科學聯盟

Dr Fuyong CHEN

Consultant

Department of Neurosurgery

The University of Hong Kong-Shenzhen Hospital

Dr Chen contributes actively in academic organizations, including Vice Chair of the 7th Youth Committee of the Chinese Society of Pain Medicine under the Chinese Medical Association, Member of the 7th Youth Committee of the Chinese Society of Neurosurgery under the Chinese Medical Association), and Vice Chair of the 7th Central Pain Working Group under the Chinese Society of Pain Medicine. Dr Chen also serves as a Council Member of the 2nd EEG and Neurophysiology Branch of the China Association Against Epilepsy, Corresponding Secretary of the Guideline Development Committee for the China Epilepsy Alliance, and Youth Member of the EEG and Neurophysiology Working Committee of the China Epilepsy Alliance. Additionally, Dr Chen contributes as an Editorial Board Member of the Chinese Journal of Minimally Invasive Neurosurgery.

Clinically, Dr Chen specializes in functional neurosurgery, neuromodulation, and magnetic resonance-guided focused ultrasound (MRgFUS), performing approximately 300 functional neurosurgical procedures annually. His expertise spans the treatment of brain functional disorders, Parkinson’s disease, epilepsy, cerebral palsy, movement disorders, hereditary spastic paraplegia, and refractory epilepsy through advanced neurosurgical interventions.

Dr Chen’s research focuses on elucidating the central mechanisms of neurological diseases and cognitive processes using functional MRI (fMRI) and intracranial electroencephalography (iEEG). In recent years, Dr Chen has authored over 20 SCI-indexed papers in high-impact journals such as Nature Human Behavior, PLOS One, Brain, PLOS Biology, NeuroImage, Computer Methods and Programs in Biomedicine, and Journal of Affective Disorders.

He has led multiple research grants, including the National Natural Science Foundation of China (NSFC) Youth Program, China Postdoctoral Science Foundation, Fujian Provincial Natural Science Foundation, Fujian Provincial Department of Education Fund, and a Key Program from the Shenzhen Science and Technology Innovation Commission.

He has contributed to 12 monographs as a co-author and translator.

He holds 2 utility model patents and 2 invention patents, along with 2 software copyrights. Additionally, 3 invention patent applications are currently pending.

Professor Calvin Pak Wing CHENG

Clinical Assistant Professor

Department of Psychiatry

School of Clinical Medicine, HKUMed

Professor Cheng has received the Fellowship of the Hong Kong College of Psychiatrists in 2014, upon completion of his medical training at The University of Hong Kong in 2007. He has joined the Department of Psychiatry at The University of Hong Kong as a clinical assistant professor since November 2017.

Professor Cheng is currently serving as an honorary associate consultant of psychogeriatric services at Queen Mary Hospital. He is also an accredited trainer of psychiatric trainees of the Hospital. He is heading the psychogeriatric day hospital services and is the representative of the clinical division of Old Age Psychiatry in the Hong Kong West Cluster. Furthermore, Professor Cheng is a former Chairman of the Young Fellows Committee of the Hong Kong College of Psychiatrists. He is also the associate editor-in-chief of the East Asian Archives of Psychiatry. He received a distinguished young fellow award from the Hong Kong Academy of Medicine in 2018.

Professor Cheng has received overseas training in brain imaging and neurostimulation. He was a visiting fellow and received training as a functional MRI researcher under Athinoula A. Martinos Center for Biomedical Imaging in the Massachusetts General Hospital in 2014. He also received training of transcranial magnetic and electrical stimulation at the Harvard Medical School, the Universitätsmedizin Göttingen and the University Medical Center Utrecht from 2014 to 2016. His current research interests reside in non-invasive transcranial brain modulation for mood disorders and cognitive impairment in the elderly.

Dr William CY LEUNG

Resident Specialist (Neurology)

Department of Medicine, Queen Mary Hospital

Dr Leung is a Specialist in Neurology at Queen Mary Hospital, The University of Hong Kong. He graduated from The University of Hong Kong in 2016, and completed his specialist training in 2023. He spent a year as a Research Fellow in Epilepsy at the Massachusetts General Hospital and Harvard Medical School (2024-2025) with Professor Andrew J Cole.

His research focuses on the prediction and management of epilepsies related to cerebrovascular pathologies. He has published in reputable journals such as Neurology, Cochrane Database of Systematic Reviews, Stroke, Journal of the American Heart Association, Vaccines, and Journal of the Neurological Sciences.

His recent honours include the Li Ka Shing Medical Fellowship (2025) and the Distinguished Young Fellow of the Hong Kong Academy of Medicine (2024). He current serves on the Board of Directors at the Epilepsy Foundation of Hong Kong.

Professor Jun LIU

Professor

Chief Physician

Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University

Professor Jun Liu successively obtained his MD and PhD degrees from Sun Yat-sen University of Medical Science during 1992 to 2002. During 2006 to 2008, he received the post-doctoral training in the University of Kansas Medical Center. He has worked in the Sun Yat-sen Memorial Hospital of Sun Yat-sen University for 20 years and was transferred to the Second Affiliated Hospital of Guangzhou Medical University in 2022.

His research field focus on the mechanisms and clinical research of neurodegenerative disease. Professor Liu is now the Head of Institute of Neuroscience of Guangzhou Medical University and National Core Advanced Cognitive Impairment Diagnosis and Treatment Center. He has led 6 National Natural Science Foundation of China grants and published more than one hundred peer-reviewed papers. In 2019, he was awarded the title of "Top Ten Outstanding Young Neurologist" sponsored by Chinese Medical Doctor Association.

Dr Yat Fung SHEA

Consultant

Department of Medicine

Queen Mary Hospital

Dr Shea Yat Fung has been a Consultant Geriatrician at Queen Mary Hospital since 2022. He specializes in dementia care, with particular interests in the application of biomarkers for Alzheimer’s disease, familial Alzheimer’s disease, and the use of anti-amyloid therapies in Hong Kong. He has completed overseas training at the Wien Center for Alzheimer’s Disease and Memory Disorders at Mount Sinai Medical Center, Miami Beach. Dr Shea is Co-Convenor of the Brain Health Special Interest Group of the Hong Kong Geriatrics Society. He is also co-first author of the Consensus Statement on the Use of Alzheimer’s Disease Biomarkers and Anti-Amyloid Therapies in Hong Kong.

Professor Yuping WANG

Professor

Chair

Department of Neurology

Xuanwu Hospital, Capital Medical University

Professor Wang is the Chair of the Department of Neurology at Xuanwu Hospital, Capital Medical University. He is one of China’s leading neurologist and neuroscientist, with clinical and research expertise spanning epilepsy, movement disorders, sleep medicine, psychosomatic diseases, and neuromodulation therapies. He found the Beijing Epilepsy Diagnosis and Treatment Centre, one of the earliest and largest specialised epilepsy centres in China, and the first to identify the cognitive-related ERP component N270, an electrophysiological marker of conflict processing and cognition-consciousness transformation.

Professor Wang has led the development of multiple innovative neuromodulation technologies, including multi-target transcranial electrical-magnetic stimulation systems and wearable brain signal regulation devices, and has developed novel therapeutic protocols for brain function disorders. He has directed numerous national research programmes under major funding schemes, and has received several top national honours, including the Chinese Medical Award, the Beijing Science and Technology Progress Award, and the Wu Jieping Medical Award.

Professor Wang also serves in key international and national roles, including Member of the Clinical Practice Guideline Working Group of the International League Against Epilepsy (ILAE), Member of the Education Committee of the World Sleep Society, Chair of the Neurology Branch of the China International Exchange and Promotive Association for Medical and Health Care, and Vice President of the China Association Against Epilepsy (CAAE).

Professor Kai ZHANG

Professor

Chief Physician

Department of Neurosurgery

Beijing Tiantan Hospital, Capital Medical University

Professor Zhang is Chief Physician, Professor, Doctoral Supervisor, and Director of the Epilepsy Surgery Ward at the Neurosurgery Center, Beijing Tiantan Hospital, Capital Medical University. He is a senior epilepsy surgeon and clinician-scientist whose work focuses on drug-resistant epilepsy, SEEG-based presurgical evaluation, functional neurosurgery, minimally invasive epilepsy surgery, and neurotechnology. His clinical practice covers the full pathway of epilepsy surgery, including multimodal neuroimaging, scalp EEG, SEEG monitoring, epileptogenic-zone localization, surgical planning, and long-term outcome evaluation.

Professor Zhang has been actively involved in advancing the clinical use of laser interstitial thermal therapy (LITT) in epilepsy surgery. His work focuses on incorporating this minimally invasive technique into the surgical management of drug-resistant epilepsy through rigorous presurgical evaluation, precise epileptogenic-zone localization, and outcome-oriented clinical assessment. By linking LITT with SEEG-based localization, multimodal imaging, and individualized surgical planning, Professor Zhang has built an integrated clinical framework for its appropriate use in epilepsy care. Through sustained clinical practice and research, he has advanced the standardized clinical application of LITT in epilepsy surgery and contributed substantially to defining its indications within the contemporary surgical management of drug-resistant epilepsy.

Professor Zhang has established substantial clinical and research resources in epilepsy surgery and invasive human neurophysiology. His team performs over 900 surgical procedures annually, including more than 200 SEEG implantation procedures, and has accumulated a large-scale invasive electrophysiological dataset. His research interests include electrophysiological signal processing, feature extraction, brain-network modelling, machine-learning-based EEG classification, and multimodal neuroimaging analysis. In recent years, he has published over 60 papers in journals including Nature Communications, PNAS, and Epilepsia, with an h-index of 32, and has led national research programmes. His work has received major national and municipal science and technology awards, including the First Prize of the National Science and Technology Progress Award and the Second Prize of the Beijing Science and Technology Progress Award.

Professor Dong ZHOU

Professor

Chief

Department of Neurology

West China Hospital, Sichuan University

Professor Zhou is a professor and consultant doctor of Department of Neurology at West China Hospital, Sichuan University. He serves as the director of the epilepsy center at West China Hospital, Sichuan University.

He is the President of the China Association Against Epilepsy, Vice Chair of Chinese Neuromodulation Society under the Chinese Medical Doctor Association, and the Chair of the EEG and Epilepsy Group of the Neurologist Branch of the Chinese Medical Doctor Association.

Internationally, he contributes as a and the Acute Symptomatic Seizures Task Force and Neuromodulation and Minimally Invasive Surgery of the International League Against Epilepsy (ILAE). He also leads the ILAE Chinese Translation Working Group for the Publications Council.

Professor Zhou received the International Epilepsy Ambassador Award in 2025, jointly conferred by the ILAE and the International Bureau for Epilepsy. He also received the First-class award of the 2020 Sichuan Provincial Science and Technology Progress Award as the primary contributor. In 2024, he received the inaugural National Outstanding Physician Award by the National Health Commission.

His research output includes 361 high-impact publications, featuring one hot paper, four highly cited papers, and an H-index of 58. He has been consecutively named the Elsevier Highly Cited Researcher in Clinical Medicine from 2020 to 2025. As a corresponding author, he has published in leading neurology titles such as Lancet Neurology (IF=45.5), Nature Reviews Neurology (IF=33.1), Nature Communications (IF=15.7), Neurology (IF=9.0), Journal of Neurology, Neurosurgery & Psychiatry (IF=7.8), and Epilepsia (IF=6.6).

He has led eight National Natural Science Foundation of China (NSFC) grants, including a Major International Cooperation and Exchange Program, and a Regional Innovation and Development Joint Fund (Key Project Category). His editorial contributions include serving as chief editor for multiple textbooks, such as the 14th Five-Year Plan Medical Planning New-Format Textbook Neurology (4th Edition), the organ-system integrated textbook Nervous System, the 11th Five-Year Plan Textbook Neurology (3rd Edition), and China’s first bilingual neurology textbook Neurology (Bilingual), alongside three monographs published by People’s Medical Publishing House. He also founded China’s first bilingual epilepsy journals, Journal of Epilepsy and Acta Epileptologica.